Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Anders Själander"'
Autor:
Christina Gummesson, Stina Alm, Anna Cederborg, Mattias Ekstedt, Jarl Hellman, Hans Hjelmqvist, Magnus Hultin, Katarina Jood, Charlotte Leanderson, Bertil Lindahl, Riitta Möller, Björn Rosengren, Anders Själander, Peter J Svensson, Stefan Särnblad, Alexander Tejera
Publikováno v:
BMC Medical Education, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background The development of entrustable professional activities (EPAs) as a framework for work-based training and assessment in undergraduate medical education has become popular. EPAs are defined as units of a professional activity requir
Externí odkaz:
https://doaj.org/article/07c499f48ad242069fd55db9f7b911c0
Autor:
Katarina Johansson, Fredrik Norström, Peter H. R. Green, Anneli Ivarsson, Linda Richter Sundberg, Anders Själander, Anna Myleus
Publikováno v:
BMC Pediatrics, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Both undiagnosed celiac disease and some chronic childhood diseases are associated with lower academic achievement. However, there is little knowledge of achievements in those diagnosed with celiac disease. Our aim was to investig
Externí odkaz:
https://doaj.org/article/7a65f1c872774b2faf53a725480b7e13
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255009 (2021)
BackgroundNephrotic syndrome (NS) is associated with increased risk of venous thromboembolism (VTE). Guidelines suggest prophylactic anticoagulants to patients with high risk of thrombosis and low risk of bleeding, but the evidence behind this is poo
Externí odkaz:
https://doaj.org/article/56db623d1a9b4067bd43a63ec7d5d371
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209187 (2018)
BACKGROUND:A combination of warfarin, aspirin and clopidogrel is indicated after percutaneous coronary intervention (PCI) in some patients, despite the higher risk of bleeding inferred by this triple therapy. OBJECTIVES:Whether the treatment quality
Externí odkaz:
https://doaj.org/article/9e1c189acd9d474791874591ed27f70b
Autor:
Vilhelm Sjögren, Björn Byström, Henrik Renlund, Peter J Svensson, Jonas Oldgren, Bo Norrving, Anders Själander
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181000 (2017)
For patients with atrial fibrillation, non-vitamin K oral anticoagulants, or NOACs (dabigatran, rivaroxaban, edoxaban, and apixaban) have been proven non-inferior or superior to warfarin in preventing stroke and systemic embolism, and in risk of haem
Externí odkaz:
https://doaj.org/article/0de3709131024bc8821454b5ee830a44
The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study
Autor:
Torsten Dahlén, Hjalmar Flygt, Anna Lübking, Ulla Olsson-Strömberg, Lovisa Wennström, Arta Dreimane, Anders Själander, Susannah Leach, Magnus Gisslén, Huiqi Li, Martin Höglund, Leif Stenke, Fredrik Nyberg
Publikováno v:
Leukemia. 37:1156-1159
Publikováno v:
European Journal of Haematology. 110:608-617
Introduction: The management to reduce risk of thromboembolic complications in polycythemia vera and essential thrombocythemia are well established, but for other conditions with elevated hemoglobin, hematocrit, or platelets there are no consensus re
Publikováno v:
Clinical Kidney Journal. 16:835-844
Background The use of direct oral anticoagulants (DOAC) in patients with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD) including dialysis is growing. Several studies have shown favorable results of DOAC compared wi
Publikováno v:
Thrombosis Research. 214:82-86
Introduction: Studies have indicated that men have a higher overall risk of VTE than women. In previous studies, we have noted that risk factors for VTE, such as alcohol consumption and physical activity, can differ between sexes. The aim of the pres
Publikováno v:
Clinical Kidney Journal. 15:1169-1178
Background Observational data comparing warfarin with no treatment for patients with non-valvular atrial fibrillation (NVAF) and severely reduced glomerular filtration rate (GFR) are conflicting and randomized controlled trials (RCTs) are lacking. Mo